novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide cuts heart by 57% versus rival Lilly weight-loss drug in study Why weight-loss drug Wegovy shows

Energy intake should also focus on appropriate macronutrient distribution and micronutrient quality

So, electrolyte-enhanced waters, functional beverages, even hydration powders, are some of the newest technologies that were tracking for our clients. Reduced appetite, reduced spending One area many CPG companies have been watching is the data that correlates GLP-1 use with reduced spending on food, due to smaller appetites while taking the drugs

Innovation drives market growth, but access depends on balancing cost, evidence, and equity

The process is designed to be clinically sound while remaining practical for everyday life